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In 2009, the Food and Drug Administration discovered that individuals taking over-the-
counter pain medications containing acetaminophen were at risk of unintentional overdose 
because these patients would supplement the painkillers with other medications containing 
acetaminophen.  This resulted in an increase in liver failures and death over the years.  To 
combat this problem, the FDA decided to lower the dosage from 1000 mg to 650 mg every four 
hours, thus reducing this risk (U.S. Food and Drug Administration).  The measures taken in this 
example demonstrate the concepts behind the field of Pharmacology.  Pharmacology is known 
as the study of the uses, effects, and mode of action of drugs (“Definition of Pharmacology”). 
Knowledge of drug concentrations is of extreme importance when determining the dosage and 
frequency in which patients are administered medication.  By ascertaining how much time is 
required to eliminate a drug, pharmacists are able to decide when the next dosage should be 
administered.  By diving into this field, we are able to answer questions such as “how much 
intravenous fluid should be administered to each individual patient?” or “Why should Tylenol 
only be taken every 4 hours?”.  Specifically, the concepts within pharmacokinetics and 
pharmacodynamics aim to explain these answers using specific mathematical systems.   
To begin, we must first understand the basic principles of pharmacokinetics.  According 
to the 2011 Nurse’s Drug Handbook, pharmacokinetics is a branch of Pharmacology. It is 
currently defined as the study of a drug’s actions as it passes through the body during 
absorption, distribution, metabolism, and excretion (2). These four parts all play a significant 
role in the movement of drugs in the human system.  Absorption implies the medication is able 
to be biologically passed through a bi-lipid cell membrane either actively or passively.  The drug 
can enter via three methods of administration, with enteral (oral), parenteral (intravenous), or 
transcutaneous (topical) drugs.  Distribution is the process of the drug being transferred to 
other regions of the body, or action sites, by bodily fluids such as one’s plasm.  The conversion 
of the drug into useful molecules and compounds is known as metabolism and occurs mainly in 
the liver, or hepatic system. Finally, excretion is the elimination of the drug from the body, 
usually taking place in the kidneys, or renal system (2011 Nurse’s Drug Handbook 4).   
Furthermore, clinical pharmacokinetics is the application of pharmacokinetic principles 
to the safe and effective therapeutic management of drugs in an individual patient (Spruill et al. 
1). Though it is not possible to directly access the sites where the drug becomes effective, such 
as in human organs, we are able to successfully measure the concentration of a drug at any 
given time via the blood, saliva, or urine.  Concentration is defined as the amount of the drug 
divided by the volume where the drug is distributed (Spruill et al. 10).  This is very useful when 
determining how a drug is distributed throughout a person’s plasma. A large volume of 
distribution indicates the drug dosage has been distributed fully into the body fluids (Spruill et 
al. 11). The volume of distribution varies considerably between patients given the fact that 
genetic differences as well as illnesses can affect the plasma concentration within that body.  
Thus, patients with a lower plasma concentration amount would require a lower dosage of a 
drug to achieve a full distribution throughout the body; something important to note when 
servicing patients hemorrhaging while receiving medication.  The concentration used to 
calculate the volume distribution is constantly changing as well due to excretion (Spruill et al. 
11).  Therefore, concentration of the drug in the bloodstream is directly proportional to the 
concentration in the tissue; higher doses of the drug implies a higher dose in the bloodstream 
and therefore higher dose diffused into the tissue.   
Pharmacodynamics refers to the relationship between drug concentration at the site of 
action and the resulting effect, including the time course and intensity of therapeutic and 
adverse effects (2011 Nurse’s Drug Handbook 5).  There are a few variables that influence the 
relationship. Time course is one of the variables defined as the length of time a drug stays at 
the receptor site which in turn determines the length of its effect.  Another is tolerance, which 
states an increased concentration over time at a receptor site can actually cause the drug’s 
effectiveness to decrease. As demonstrated in the graph to the left, when the number of doses 
increases, the drug concentration must also increase to get the same desired effect because the 
human body develops a resistance to 
the drug (Spruill et al. 3).  Human 
bodies increase its metabolism so a 
drug is excreted from the body quicker 
and its time in the body decreases.  
Conversely, bacteria have internal 
survival responses that allow the 
bacteria to create protective barriers 
that provide a resistance to certain 
drugs the more it is exposed. This is 
why the long term use of non-steroidal anti-inflammatory drugs, such as ibeprophen, and 
repeated use of antibiotics may actually be detrimental to the human body. 
The ways in which drugs are received by the body differ by the type of drug and the 
drug’s mode of action.  For example, a medication that aids in lowering blood pressure will 
target the autorhythmic cells in the human heart to block the release of calcium, thereby 
slowing contractions in the heart and lowering mean arterial pressure.  But an antibiotic like 
penicillin, that targets foreign bacteria in the body, will attach to the bacterial cell, preventing 
the cell from forming a protective cell wall and causing it to die.  Each drug has different 
mechanisms because receptor sites vary (Spruill et al. 2).   As a result, the concentration at the 
receptor site must vary accordingly, proving the importance of understanding these biological 
processes. 
Given this knowledge of pharmacokinetics and pharmacodynamics, we can now look 
into some mathematical systems. We will soon be able to predict the amount of drugs in the 
bloodstream, and therefore tissue, at any given time and determine the rate at which it is 
leaving.  This is achieved through compartment models (Spruill et al. 8).  The compartments in a 
given model represent the locations where the drug travels throughout the body, for instance, 
the blood stream, and organ tissues, or urine.   The simplest form is the one-compartment 
model and is in fact a first order model.   
In this instance, the drug is administered 
into the body, enters the plasma, and is excreted 
from the compartment.  This can also be looked at 
in mathematical terms.  There is the initial amount 
of the dosage, the compartment, which is the 
concentration of the drug in the body, and the movement out is the rate at which the drug is 
leaving, or the rate of change.  Since this rate is decreasing exponentially, we can utilize the 
exponential decay function to determine the amount of the drug at any given time. The rate of 
change in the concentration is proportional to the current concentration so we start off with 
the equation 
𝑑𝑃
𝑑𝑡
= 𝑃𝑘 where k is the growth rate, P is the current amount, and dP/dt is the rate 
of change.  This equation is separable so  
1
𝑃
𝑑𝑃 = 𝑘𝑑𝑡 
  ∫
1
𝑃
𝑑𝑃 =  ∫ 𝑘𝑑𝑡 
  𝑙𝑛|𝑃| = 𝑘𝑡 + 𝐶 
  𝑃 =  𝑒𝑘𝑡+𝐶 =  𝑒𝑘𝑡𝑒𝑐  
  𝑃 = 𝑃𝑜𝑒
𝑘𝑡 
According to Calculus: Single Variable, “Every solution to the equation dP/dt = kP can be 
written in the form P = Poekt, where Po is the value of P at t = 0, and k>0 represents growth, 
whereas k <0 represents decay”(Gleason, Hughes-Hallett, McCallum 13).   By utilizing this 
equation, we can solve real life applications.  For instance, “The rate at which a drug leaves the 
bloodstream and passes into the urine is proportional to the quantity of the drug in the blood 
at that time.  If an initial dose of Qo is injected directly into the blood, 20% is left in the blood 
after 3 hours.  Write an equation and solve for the quantity Q of the drug in the blood after t 
hours” (Gleason, Hughes-Hallett, McCallum 618).  Since 20% is left, we know 𝑄𝑜 = 1 and  
𝑄(3) = 0.2 so we can use our decay function 𝑄 = 𝑄𝑜𝑒
𝑘𝑡 and solve for k. Therefore, we can 
plug 
        0.2 = 𝑒𝑘3 
   𝑙𝑛|0.2| = 𝑘3 
   k= -.536479 
   𝑄 = 𝑄𝑜𝑒
−0.536479𝑡 
Additionally if we plug in a time value and initial dosage amount, we can determine how much 
of a drug is in a patient’s body at that time. 
Also, “The half-life of an exponentially decaying quantity is the time required for half of 
it to decay” (Gleason, Hughes-Hallett, McCallum 14).  It correlates with the duration of action in 
the hepatic and renal systems.  The longer the half-life, the less often the drug needs to be 
administered and the longer it remains in the body (Spruill et al. 33).   Half-life is useful in the 
medical field for two reasons: it reveals how long it takes for the body to completely eliminate 
the drug from the body as well as how frequent the doses should be given out (Gordon).  
Within the biological setting, it takes 4.5 half-lives for a drug to be 95% eliminated so by 
multiplying the half-life time by 4.5, the time span before the next dosage is revealed (Gordon).   
After being introduced to the concept of one compartment models, we can now dive 
into two compartment models.  This is a situation in which the drug passes through two 
separate locations within the body including the blood, organs and tissues, or urine.  This 
effects the amount of the drug in the body because now it is being metabolized in two places at 
different rates.  The right 
hand picture 
demonstrates this 
process and gives us the 
following system of 
equations to model it accordingly (Koch-Noble 237).   
 
dg
dt
= 𝑓(𝑡) − βg(t). 
db
dt
= βg(t) − αb(t). 
In this instance,  
 𝑓(𝑡)= initial dosage of ingestion at time 0 
𝑏(𝑡)= amount of drug in the bloodstream at time t 
𝑔(𝑡)= amount of drug in the gastrointestinal tract (GI tract) at time t 
𝛼, 𝛽= the metabolism of the drug in the bloodstream and GI tract, respectively 
This is a non-homogeneous equation because 𝑓(𝑡) does not play a direct role on the other 
functions.  So to solve, we want to turn the system into a second order linear equation. 
Generally, a second order linear equation is written in the form of  𝐴𝑦′′ + 𝐵𝑦′ + 𝐶𝑦 = 0. To 
solve, let 𝑦 = 𝑒𝑟𝑡 and insert into the general formula.   
⟹ 𝑟2𝑒𝑟𝑡 + 𝑟𝑒𝑟𝑡 + 𝑒𝑟𝑡 = 0 
⟹ 𝑟2 + 𝑟 + 1 = 0  
This last equation is the characteristic equation which we will utilize later.  When the quadratic 
is solved, if we get distinct real roots for 𝑟, the general solution for a homogeneous equation is 
𝑦ℎ = 𝐶1𝑒
−𝑟1𝑡 + 𝐶2𝑒
−𝑟2𝑡. 
Furthermore, the solution to a non-homogeneous equation is 𝑦 = 𝑦ℎ + 𝑦𝑝where p is the 
particular solution.  We can use this to solve our system modeling the two compartments. We 
start with the system,  
dg
dt
= 𝑓(𝑡) − βg(t). 
db
dt
= βg(t) − αb(t). 
We rewrite these equations to factor out g(t), 
[D + β][g(t)] = 1  
−𝛽[g(t)] + [D + α][b(t)] = 0 
(Note D represents derivative in terms of t and 𝑓(𝑡) = 1) 
We want the g(t) terms to have the same “coefficients” to solve by elimination so we multiply 
the top equation by 𝐷 + β and the bottom equation by 𝛽, 
𝛽[D + β][g(t)] = 𝛽  
[D + β](−𝛽[g(t)] + [D + α][b(t)]) = 0 
Adding the two equations will eliminate the g(t) terms and give us,  
⇒ [D + β][D + α][b(t)] = 𝛽 
When we foil, we get 
⇒ 𝑏′′ + (𝛽 + 𝛼)𝑏′ + 𝛽𝛼𝑏 = 𝛽  
Now we use the characteristic equation discussed earlier, 
⇒ 𝑟2 + (𝛽 + 𝛼)𝑟 + 𝛽𝛼 = 0 
⟹ (𝑟 + 𝛽)(𝑟 + 𝛼) = 0 so 𝑟 = −𝛽 𝑎𝑛𝑑 − 𝛼 
The homogeneous solution is then,  
𝑏ℎ = 𝐴𝑒
−𝛼𝑡 + 𝐵𝑒−𝛽𝑡 
We must also consider the particular solution since this system is non-homogeneous.  To do so, 
we let the particular solution be represented by a variable, 
𝑏′′ + (𝛽 + 𝛼)𝑏′ + 𝛽𝛼𝑏 = 𝛽 
𝐿𝑒𝑡 𝑏𝑝 = 𝐾 
We plug this in and get, 
𝛽𝛼𝐾 = 𝛽 
⟹ 𝐾 =
1
𝛼
 
So our complete equation is,  
𝑏(𝑡) = 𝐴𝑒−𝛼𝑡 + 𝐵𝑒−𝛽𝑡 +
1
𝛼
 
Here 𝑏(𝑡) is the amount of drugs in the bloodstream in terms of time, 𝑡.   𝐴 and 𝐵 are the drug 
amounts of the first and second compartment, respectively.  𝛼 and 𝛽 are the decay rate 
constants for each compartment(Spruill et al. 78).  Using this model, we can determine the 
amount of the drug in the blood at any given time when the drug passes into two 
compartments.   
 In this final portion on the paper, we will look at how multiple injections can be 
modelled over time by using ordinary differential equations (ODEs).  In these cases, a patient 
would be receiving drug doses at regular intervals and between each injection, the drug would 
be metabolized.  This creates a model in which a discrete function is a part of a continuous 
function (Koch-Noble 235).  We can start off with the equation,  
db
dt
= 𝑓(𝑡) − αb(t)  
𝑏(𝑡)= amount of drug in the bloodstream at time t 
𝑓(𝑡)= dosing pattern of injections at time t (This is a discrete value since dosages will remain 
constant) 
α = metabolism of the drug 
It is interesting to note in the absence of another injection, or when 𝑓(𝑡)= 0, the model will 
function just as the exponential decay function examined earlier in this paper.  In this case, the 
drug will be fully excreted from the bloodstream as expected.  However, the constant injections 
force the concentration of the drug to spike back up to the initial value and the decay cycle 
restarts. 
The given ODE indicates that the rate at which the amount of a drug in the bloodstream is 
changing over a period of time (continuous) while injections of the drug are being administered 
(discrete).  We want to transform this into a function that will tell us the amount of the drug in 
the bloodstream at any given time.  To do so, we will utilize the Laplace transform. 
First, we will look at the basic properties of three elements needed to solve the equation: 
the Laplace transform, step function, and Dirac delta function.  The Laplace transform of a 
function is a way to evaluate ODE’s in a simpler manner. It is defined as   
ℒ{𝑓(𝑡)} = ∫ 𝑒−𝑠𝑡𝑓(𝑡)𝑑𝑡
∞
0
  
so long as the integral converges and 𝑓(𝑡) doesn’t grow larger than the exponential. Then when 
the integral is evaluated, we get a new function F(s).  Thus, 
ℒ{𝑓(𝑡)} = 𝐹(𝑠) where s is similar to a frequency space 
This model also utilizes the step function, designated by 𝑢(𝑡). The definition of the step 
function states that,  
𝑢(𝑡) = {
0, 𝑡 < 0
1, 𝑡 > 0
 
This essentially means that when t is equivalent to 𝑎𝑛 we get a value of 1 and the function is 
turned on.  Practically speaking, this means if the time when the drug amount is measured is 
the same as the time when the drug is injected, we will get a value.  It is also important to note 
that the derivative of the step function is the delta function,         
𝑑
𝑑𝑡
𝑢(𝑡) =  𝛿(𝑡) 
The Dirac delta function is defined as a linear functional from a space of test functions 
𝑓  . The action of 𝛿 on 𝑓 gives the value at 0 of 𝑓 for any function 𝑓(“Dirac Delta Function”).  By 
definition, 
∫ 𝑔(𝑡)𝛿(𝑡 − 𝑎)𝑑𝑡 = 𝑔(𝑎)
∞
−∞
 
Identities include, 
𝛿(𝑡) = {
0, 𝑡 ≠ 0
∞, 𝑡 = 0
 
∫ 𝛿(𝑡)𝑑𝑡 = 1
∞
−∞
. 
 
When time is not equal to 0 the resulting value is 0, but when t = 0, or any time a, the impulse 
occurs and we get a value.  Whenever we have 𝛿(𝑡 − 𝑎), we have an impulse shift to time a, 
but the area is still 1 (“Dirac Delta Function”).  
𝛿(𝑡 − 𝑎) = {
0, 𝑡 ≠ 𝑎
"∞", 𝑡 = 𝑎
 
Since 𝑓(𝑡) is defined as the discrete pulse function, it is actually a delta function.  So,  
𝑓(𝑡) =  𝛿(𝑡 − 𝑎1) +  𝛿(𝑡 − 𝑎2) + ⋯ + 𝛿(𝑡 − 𝑎𝑛) 
where 𝑎𝑛 is the time when dosage number, n, is administered.  
 
With those in mind, we can solve the ODE.  We start off with the equation, 
db
dt
= 𝑓(𝑡) − αb(t). 
We can utilize the Laplace transform to solve this ODE. So we take the Laplace transform of the 
left and right hand side of our equation.   
ℒ {
db
dt
} = ℒ{𝑓(𝑡) − αb(t)}. 
Linearity properties allow us to take the Laplace transform on both sides, from each component 
on the right hand side, and factor out α as a constant,  
ℒ {
db
dt
} = ℒ{𝑓(𝑡)} − αℒ{b(t)}. 
To evaluate, we can look at each side separately.  When looking at a table of Laplace transforms 
(Dawkins), we can use the Laplace transform definition to solve ℒ {
db
dt
} , 
ℒ {
db
dt
} = ∫ 𝑒−𝑠𝑡
db
dt
𝑑𝑡
∞
0
 
We solve this by using integration by parts which says ∫ 𝑢𝑣′ = 𝑢𝑣 −  ∫ 𝑣𝑢′, so we can assign 𝑢 
and 𝑣′ to parts of our integral and evaluate,  
𝑢 = 𝑒−𝑠𝑡        𝑣′ =
db
dt
𝑑𝑡 
𝑢′ = −𝑠𝑒−𝑠𝑡 𝑑𝑡       𝑣 =  𝑏(𝑡) 
⇒ 𝑒−𝑠𝑡 𝑏(𝑡)|𝑡=0
𝑡=∞       +  ∫ 𝑠𝑒−𝑠𝑡𝑏(𝑡)𝑑𝑡
∞
0
 
⇒ −𝑏(0) + 𝑠 ⋅ 𝐵 
Therefore we get number 35 on our Laplace transform table, 
𝑠 ⋅ 𝐵 − 𝑏(0) 
where 𝐵 is our new function and 𝑏(0)  is our initial amount of the drug. 
 
 We then use the Laplace transform for both functions on the right hand side, utilizing the table 
once again (Dawkins). 
ℒ{𝑓(𝑡)} − αℒ{b(t)}. 
⇒ ℒ{𝛿(𝑡 − 𝑎1) +  𝛿(𝑡 − 𝑎2) + ⋯ + 𝛿(𝑡 − 𝑎𝑛)} − αℒ{b(t)}. 
When we take the Laplace transform of the delta function, the definition of the Laplace 
transform gives us the solutions through a simple substitution of variables,  
ℒ{𝛿(𝑡 − 𝑎)} = ∫ 𝑒−𝑠𝑡𝛿(𝑡 − 𝑎)𝑑𝑡 = 𝑒−𝑎𝑠
∞
0
 
So our right hand side solution turns out to be,  
 
⇒ (𝑒−𝑎1𝑠 +  𝑒−𝑎2𝑠 + ⋯ +  𝑒−𝑎𝑛𝑠) −  α ⋅ 𝐵 (by 26 and the definition) 
Finally, both sides are combined and algebra is used to rearrange the terms so the 𝐵 
terms are on the left and the 𝑠 terms are on the right. 
𝑠 ⋅ 𝐵 − 𝑏(0)  = (𝑒−𝑎1𝑠 +  𝑒−𝑎2𝑠 + ⋯ +  𝑒−𝑎𝑛𝑠) −  α ⋅ 𝐵 
⟹ 𝑠 ⋅ 𝐵 + α ⋅ 𝐵  = (𝑒−𝑎1𝑠 +  𝑒−𝑎2𝑠 + ⋯ +  𝑒−𝑎𝑛𝑠) + 𝑏(0) 
⟹ 𝐵(𝑠 + α)   = (𝑒−𝑎1𝑠 +  𝑒−𝑎2𝑠 + ⋯ +  𝑒−𝑎𝑛𝑠) + 𝑏(0) 
⟹ 𝐵   = 
( 𝑒−𝑎1𝑠+ 𝑒−𝑎2𝑠+⋯+ 𝑒−𝑎𝑛𝑠)+𝑏(0)
(𝑠+α)
 
Now we use the inverse Laplace transform to convert our equation for B back into b(t), applying 
the inverse transform it to each component.  
ℒ−1{𝐵} = ℒ−1 {
𝑏(0)
(𝑠+α)
} +  ℒ−1 {
𝑒−𝑎1𝑠
(𝑠+α)
} + ℒ−1 {
𝑒−𝑎2𝑠
(𝑠+α)
} + ⋯ + ℒ−1 {
𝑒−𝑎𝑛𝑠
(𝑠+α)
} 
 
Note,  
ℒ−1 {
𝑒−𝑎𝑛𝑠
(𝑠+α)
} =  ℒ−1{𝑒−𝑎𝑛𝑠  ⋅ 𝐹}  where 𝐹 =
1
(𝑠+α)
 
There are four steps to solve.  First, identify 𝐹 which we set equal to 
1
(𝑠+α)
.  Then we take the 
inverse Laplace transform of 𝐹 to get 𝑓(𝑡) by the definition. After, we replace 𝑡 with 𝑡 − 𝑎𝑛  
and finish by multiplying 𝑓(𝑡) by the step function.  We can do this because as stated earlier, 
the derivative of the step function is the delta function.  After doing so, we get, 
ℒ−1{𝑒−𝑎𝑛𝑠  ⋅ 𝐹} = 𝑓(𝑡 − 𝑎𝑛) ∙ 𝑢(𝑡 − 𝑎𝑛)  (27) 
We use the Laplace transform table again and plug in 
𝑓(𝑡) =  𝑒−∝𝑡(2)  
Once this is done for every component, we get the final equation,  
𝑏(𝑡) = 𝑏(0)𝑒−∝𝑡 + 𝑢(𝑡 − 𝑎1)𝑒
−∝(𝑡−𝑎1) + 𝑢(𝑡 − 𝑎2)𝑒
−∝(𝑡−𝑎2) + ⋯ +  𝑢(𝑡 − 𝑎𝑛)𝑒
−∝(𝑡−𝑎𝑛) 
With the use of this equation, we can now determine the amount of the drug in the 
body at time, t.  As time goes on, more of the function is turned on and the result is a 
temporary spike in the concentration.  This spike cannot increase much though because the 
exponential decay function is attached to it, causing a decrease in the drug concentration.  
When 𝑏(𝑡) is graphed, the result is exactly as we would expect. 
 
 
 
 
 
 
In this graph, the bottom of the curve is when the drug reaches its minimum effective 
concentration, the peak is its minimum toxic concentration, and the whole curve is the 
therapeutic window which is the range in which the drug is working effectively (Koch-Noble 
238).  As discussed previously, every individual drug has its own chemical properties and are 
effected by factors in the body differently.  For some drugs, it is preferable to give smaller doses 
more frequently while with others it is preferable to give larger doses over longer time 
intervals.  Larger, less frequent doses cause the therapeutic range to be greater (longer time 
from peak to pit).  This can be a disadvantage because there is a greater chance of staying in 
the toxic range or subtherapeutic range longer. Likewise, smaller, more frequent doses may not 
be practical when it comes to administering (Spruill et al. 60). 
 To conclude, we have looked at just a few of the models that aid in modeling drug 
injection types within the field of pharmacokinetics.  While the complexity of each formula 
varies, the result is the same; we are able to determine the amount of a drug within the body at 
any given time.  However, it is important to note there are multiple other factors that play a 
role in this amount.  One’s ability to metabolize a single drug fluctuates between patients. 
Interactions between two or more medications may also influence the rate of decay.  With an 
insight into the workings of pharmacodynamics, these factors can be considered and may be 
adjusted for in our mathematical interpretations.  By generating these models, we can develop 
a deeper understanding of how drugs operate in order to further the effectiveness of their 
administration, thus accomplishing the ultimate goal of improving the patient’s well-being.   
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